• Taking the First Scary Step After My LEMS Diagnosis
  • Triple-Timed Up-and-Go Test Effective in Assessing LEMS Severity, Trial Analysis Shows
  • World’s First Alport Stamp Is Macedonian Mom’s Latest Win for Rare Disease Patients
  • As a LEMS Patient, I’m Concerned About the Ongoing IVIG Shortage
  • Autoantibodies Against GRP78 May Underlie PCD in LEMS, Study Suggests
  • ‘LEMme Tell Ya’ About Me and My Extremely Rare Disease
  • NORD Honors Industry, Patient Advocates at Rare Impact Awards Gala
  • Eurordis Unveils Integrated-care Initiative for Rare Disease Patients
  • ‘Rare Barometer’ Program Helps Eurordis Shape EU Rare Disease Policy
  • Catalyst Expands Firdapse’s License Coverage to Include Japan, Sues FDA Over Ruzurgi’s Approval
  • Patients with SCLC-LEMS Easier to Diagnose, More Likely to Have Ataxia, Study Says
  • Agency Unveils RaDaR to Help Patient Groups Develop Rare Disease Registries